Skip to main content
Neuland Laboratories Limited. logo

Neuland Laboratories Limited. — Investor Relations & Filings

Ticker · NEULANDLAB ISIN · INE794A01010 LEI · 335800AVHZURTYQ17N08 BSE.NS Manufacturing
Open in API
Filings indexed 947 across all filing types
Latest filing 2019-08-02 Regulatory Filings
Country IN India
Listing BSE.NS NEULANDLAB

About Neuland Laboratories Limited.

https://www.neulandlabs.com

Neuland Laboratories Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and provides comprehensive Custom Manufacturing Solutions (CMS). The company focuses on complex chemistry and high-quality standards, operating state-of-the-art manufacturing facilities that comply with international regulatory requirements, including those of the USFDA and EDQM. Its product portfolio spans diverse therapeutic areas such as cardiovascular, central nervous system, anti-infectives, and antiasthmatics. Neuland supports pharmaceutical companies globally through the entire lifecycle of a drug, from early-stage clinical development to commercial-scale production. By leveraging advanced technical expertise and a robust quality management system, the organization delivers reliable chemical synthesis and process optimization services to both innovator and generic drug manufacturers.

Recent filings

Filing Released Lang Actions
Credit Rating
Regulatory Filings Classification · 95% confidence The document is very short (447 characters) and contains a table with credit ratings from CARE agency, showing existing and revised ratings for long-term and short-term bank facilities. There is no indication of a full report, financial statements, or detailed analysis. The content resembles a credit rating update or notice rather than a full financial report or detailed filing. Given the brevity and nature of the content, it does not fit into detailed report categories like Annual Report, Interim Report, or Earnings Release. It also does not match categories like Board/Management changes or Legal Proceedings. The best fit is Regulatory Filings (RNS), which is a fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories. Confidence is high due to the clear nature and short length of the document.
2019-08-02 English
Press Release
Regulatory Filings Classification · 95% confidence The document text is extremely short (112 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, report title, regulatory references, or any descriptive text. Given the lack of content, this cannot be classified as a report or announcement of a report. It fits best as a Regulatory Filing (RNS) which is the fallback category for miscellaneous filings without specific classification.
2019-07-17 English
Board Meeting — Financial Results
Regulatory Filings Classification · 100% confidence The document text is extremely short (58 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, no report content, no announcements, or any other information to classify as a specific report type. Given the lack of content, the document does not fit any specific filing category and defaults to the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2019-07-16 English
Updates
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2019. It is a compliance certificate from the Registrar and Share Transfer Agent certifying details of securities dematerialized/rematerialized during the quarter. The document is short (4412 characters) and primarily serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or detailed financial data. It is not an announcement of a report but a certificate under a specific regulatory requirement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance certificates and miscellaneous regulatory documents.
2019-07-10 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 90% confidence The document text contains only placeholders for images and no textual content or substantive information. It is extremely short (161 characters) and does not contain any report, announcement, or financial data. Given the lack of content, it cannot be classified as any specific report or announcement type. It fits best as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings without substantive content.
2019-07-05 English
Updates
Annual Report Classification · 100% confidence The document is a detailed report from Neuland Laboratories Limited for the financial year 2018-19. It includes a letter referencing the Annual Report, corrections to the Annual Report, and a comprehensive table of contents listing Management Reports, Statutory Reports, and Financial Statements. The content includes messages from the Chairman and CEO, detailed discussions on business performance, financial performance, and operational updates. The length is substantial (15,000 characters), and the document contains actual financial data and analysis rather than just an announcement or certification. Therefore, this document fits the definition of an Annual Report (10-K).
2019-07-05 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.